LSLaura Saso-Jiménez

Laura Saso-Jiménez

*This is an algorithmically generated author record based on publicly available information.

Laura Saso-Jiménez has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A genetic risk approach to differential diagnosis of type 1 diabetes and risk stratification in the Spanish population

    by Laura Saso-Jiménez, Inés Urrutia, Maitane González-Arceo, Héctor Diez, Josu Aurrekoetxea-Oribe, Begoña Calvo, Jose Ramón Bilbao, Itxaso Rica, Nuria Valdés, Alicia Huerta-Chagoya, et al.

    Context: Accurate type 1 diabetes (T1D) risk assessment can improve diagnosis and preventive care, reducing misdiagnosis and enabling preclinical interventions. Genetic risk scores (GRS) offer a promising tool, but population-specific validation is required. Objective: This study aims to assess the performance of established scores vs a novel Spanish-specific GRS for T1D differential diagnosis and risk stratification. Methods: From 2338 genotyped individuals, 2215 Spanish participants of European ancestry passed quality control: 816 T1D, 469 type 2 diabetes (T2D), 457 monogenic diabetes (MD), and 473 controls. A novel Spanish-specific GRS (T1D-SP-GRS) was developed and compared with HLA-DRB1 and 2 European-derived models (T1D-GRS and T1D-GRS2). The best-performing score was evaluated for T1D discrimination vs T2D and MD and for association with T1D-onset age. Results: T1D-GRS2 outperformed T1D-SP-GRS for T1D vs controls (AUC-ROC: 0.888 [95% CI: 0.867-0.908] vs 0.837 [0.797-0.877], P = .001), retaining high discrimination vs T2D and MD (0.886 [0.865-0.907]). In the combined pediatric-onset T1D and control cohort, the P50 cutoff yielded a sensitivity of 0.80 (95% CI: 0.76-0.84) and specificity of 0.81 (0.77-0.84); P25 prioritized sensitivity (0.97 [0.95-0.99]) while P75 specificity (0.96 [0.93-0.97]). A P90 threshold conferred 26-fold higher T1D odds vs controls and 18- and 17-fold vs T2D and MD (P < .001). Higher T1D-GRS2 in childhood- vs adulthood-onset T1D revealed an age-dependent risk profile primarily driven by HLA. Conclusions: T1D-GRS2 discriminates T1D from other diabetes etiologies, providing a complementary tool to support diagnostic accuracy. The higher genetic risk associated with a younger age at onset provides key insights for early-stage T1D screening and intervention strategies.

  • Open Access

    Searching for Monogenic Autoimmune Etiology in Patients With Type 1 Diabetes Onset Before 30 Months of Age

    by Laura Saso-Jiménez, Inés Urrutia, Begona Calvo, José Ramón Bilbao, Ana Lucía Gómez-Gila, Isabel Leiva-Gea, Andrea Jiménez-Sanchis, Itxaso Rica, Luis Castano, Rosa Martínez

    Introduction: The most frequent form of diabetes in pediatric patients is polygenic autoimmune diabetes (type 1 diabetes [T1D]), but single-gene variants responsible for autoimmune diabetes have also been described. Both disorders share clinical features, which can lead to monogenic forms being misdiagnosed as T1D. However, correct diagnosis is crucial for therapeutic choice, prognosis, and genetic counseling. The aim of this study was to search for monogenic autoimmune diabetes in Spanish pediatric patients with early-onset T1D. Methods: Among 500 Spanish pediatric patients with T1D, those with disease onset between 9 and 30 months of age were selected for screening for monogenic autoimmune diabetes (n = 44). Genetic testing was performed by next-generation sequencing with a customized panel that included the major causative genes for monogenic autoimmune syndromes, including early-onset diabetes: AIRE, CTLA4, FOXP3, IL2RA, ITCH, LRBA, STAT1, STAT3, STAT5B. RT-PCR and cDNA sequencing of the RNA isolated from whole blood were used to analyze splicing variants. Results: Genetic screening identified, in 2 patients with diabetes onset before 1 year of age, 2 likely pathogenic novel variants affecting canonical splicing sites: c.286-12_290del in STAT5B and c.-22-2delA in FOXP3. RNA analyses demonstrated that both variants modify mRNA splicing. The variant in STAT5B induced exon 4 skipping and the variant in FOXP3 caused a deletion of 16 nucleotides before the transcription start site. Conclusion: T1D onset in the first year of life may indicate monogenic autoimmune diabetes and molecular testing may be recommended.


  • Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype

    by Inés Urrutia, Rosa Martínez, Begona Calvo, Laura Saso-Jiménez, Pedro González, Elsa Fernández-Rubio, Alicia Martín-Nieto, Anibal Aguayo, Itxaso Rica, Sonia Gaztambide, et al.

    Context: Autoimmune diabetes can develop at any age, but unlike early-onset diabetes, adult onset is less well documented. We aimed to compare, over a wide age range, the most reliable predictive biomarkers for this pathology: pancreatic-autoantibodies and HLA-DRB1 genotype. Methods: A retrospective study of 802 patients with diabetes (aged 11 months to 66 years) was conducted. Pancreatic autoantibodies at diagnosis: insulin autoantibodies (IAA), glutamate decarboxylase autoantibodies (GADA), islet tyrosine phosphatase 2 autoantibodies (IA2A), and zinc transporter-8 autoantibodies (ZnT8A) and HLA-DRB1 genotype were analyzed. Results: Compared with early-onset patients, adults had a lower frequency of multiple autoantibodies, with GADA being the most common. At early onset, IAA was the most frequent in those younger than 6 years and correlated inversely with age; GADA and ZnT8A correlated directly and IA2A remained stable. The absence of HLA-DRB1 risk genotype was associated with higher age at diabetes onset (27.5 years; interquartile range [IQR], 14.3-35.7), whereas the high-risk HLA-DR3/DR4 was significantly more common at lower age (11.9 years; IQR, 7.1-21.6). ZnT8A was associated with DR4/non-DR3 (odds ratio [OR], 1.91; 95% CI, 1.15-3.17), GADA with DR3/non-DR4 (OR, 2.97; 95% CI, 1.55-5.71), and IA2A with DR4/non-DR3 and DR3/DR4 (OR, 3.89; 95% CI, 2.28-6.64, and OR, 3.08; 95% CI, 1.83-5.18, respectively). No association of IAA with HLA-DRB1 was found. Conclusion: Autoimmunity and HLA-DRB1 genotype are age-dependent biomarkers. Adult-onset autoimmune diabetes is associated with lower genetic risk and lower immune response to pancreatic islet cells compared with early-onset diabetes.